Loading...
Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase()()
Panobinostat, a histone deacetylase inhibitor, induces histone acetylation and acts against cancer but attenuates its anticancer activity by activating the mammalian target of rapamycin (mTOR) pathway. AMP-activated protein kinase (AMPK) is a cellular energy sensor that reportedly inhibits the mTOR...
Saved in:
| Published in: | Transl Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Neoplasia Press
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6402380/ https://ncbi.nlm.nih.gov/pubmed/30849634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.02.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|